International Society for the Study of Vascular Anomalies classification for vascular anomalies. http://issva.org/classification (accessed 14 December 2014)Google Scholar

Miettinen, M., Lindenmayer, A.E., and Chaubal, A. (1994). Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens – evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol, 7, 82–90Google Scholar

DeYoung, B.R., Swanson, P.E., Argenyi, Z.B., et al. (1995). CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol, 22, 215–22Google Scholar

McKenney, J.K., Weiss, S.W., and Folpe, A.L. (2001).CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol, 25, 1167–73CrossRefGoogle ScholarPubMed

Thum, C., Husain, E.A., Mulholland, K., et al. (2013). Atypical fibroxanthoma with pseudoangiomatous features: a histologic and immunohistochemical mimic of cutaneous angiosarcoma. Ann Diagn Pathol, 17, 502–7Google Scholar

Sapino, A., Bongiovanni, M., Cassoni, P., et al. (2001). Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol, 194, 254–61Google Scholar

Manner, J., Radlwimmer, B., Hohenberger, P., et al. (2010). MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol, 176, 34–9CrossRefGoogle ScholarPubMed

Fernandez, A.P., Sun, Y., Tubbs, R.R., et al. (2012). FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol, 39, 234–42CrossRefGoogle ScholarPubMed

Mentzel, T., Schildhause, H.U., Palmedo, G., et al. (2012). Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification on contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol, 25, 75–85Google Scholar

Kahn, H.J., Bailey, D., and Marks, A. (2002). Monoclonal antibody D2–40, a new marker of lymphatic endothelium reacts with Kaposi's sarcoma and a subset of angiosarcoma. Mod Pathol, 15, 434–40Google Scholar

Miettinen, M., Wang, Z.F., Paetau, A., et al. (2011). ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol, 35, 432–44Google Scholar

Miettinen, M., Wang, Z., Sarlomo-Rikala, M., et al. (2013). ERG expression in epithelioid sarcoma: a diagnostic pitfall. Am J Surg Pathol; 37 (10), 1580–5.Google Scholar

Folpe, A.L., Chand, E.M., Goldblum, J.R., et al. (2001). Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol, 25, 1061–6.Google Scholar

Rossi, S., Orvieto, E., Furlanetta, A., et al. (2004). Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol, 17, 547–52Google Scholar

North, P.E., Waner, M., Mizeracki, A., et al. (2000). GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol, 31, 11–22Google Scholar

Banerji, S., Ni, J., Wang, S.X., et al. (1999). LYVE-1 a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol, 144, 789–801Google Scholar

Paipainen, A., Korhonen, J., Mustonen, T., et al. ( 1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA, 92, 3566–70Google Scholar

Folpe, A.L., Veikkola, T., Valtola, R., et al. (2000). Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol, 13 (2), 180–5Google Scholar

Lawley, L.P., Cerimele, F., Weiss, S.W., et al. (2005). Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol, 141, 1297–300Google Scholar

Al Dhaybi, R., Powell, J., McCuaig, C., et al. (2010). Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol, 63, 1052–7Google Scholar

Requena, L., Kutzner, H., and Mentzel, T. (2000). Acquired elastotic hemangioma: A clinicopathologic variant of hemangioma. J Am Acad Dermatol, 47, 371–6Google Scholar

Martorell-Calatayud, A., Balmer, N., Sanmartin, O., et al (2010). Definition of the features of acquired elastotic hemangioma, reporting the clinical and histopathologic characteristics of 14 patients. J Cutan Pathol, 37, 460–4Google Scholar

Tong, P.L., and Beer, T.W. Acquired elastotic hemangioma: ten cases with immunohistochemistry refuting a lymphatic origin in most lesions (2010). J Cutan Pathol, 37, 1259–60Google Scholar

Zampetti, A., Orteu, CH., Antuzzi, D., et al (2012). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. Br J Dermatol, 166, 712–20CrossRefGoogle ScholarPubMed

Nakamura, T., Kaneko, H., and Nishino, I. (1976). Angiokeratoma corporis diffusum (Fabry's disease): a lysosomal disease. Arch Dermatol, 112, 1416–23Google Scholar

Trindade, F., Torrelo, A., Kutzner, H., et al (2014). An immunohistochemical study of angiokeratomas of children. Am J Dermatopathol, 10, 796–9Google Scholar

Wang, L., Yuan, W., Geng, S., et al (2014). Expression of lymphatic markers in angiokeratomas. J Cutan Pathol, 41, 576–81Google Scholar

Enzinger, F.M., and Weiss, S.W. (1988). Soft tissue tumors. 2nd ed. St. Louis: The C.V. Mosby Company.Google Scholar

Girard, C., Graham, J.H., Johnson, W.C. (1974). Arteriovenous hemangioma (arteriovenous shunt): A clinicopathologic and histochemical study. J Cutan Pathol, 1, 73CrossRefGoogle ScholarPubMed

Connelly, M.G., and Wingelmann, R.K. (1985). Acral arteriovenous tumor. A clinicopathologic review. Am J Surg Pathol, 9, 15–21Google Scholar

Koutlas, I.G., and Jessurum, J. (1994). Arteriovenous hemangioma: a clinicopathologic and immunohistochemical study. J Cutan Pathol, 21, 343–9Google Scholar

Kanitakis, J., Roger, H., Soubrier, M., et al. (1988). Cutaneous angiomas in POEMS syndrome. An ultrastructural and immunohistochemical study. Arch Dermatol, 124, 695–8Google Scholar

Hogarth, V., Dhoat, S., Mehta, A.B., and Orteu, C.H. (2011). Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas. Clin Exp Dermatol, 36, 506–8Google Scholar

Fajgenbaum, D.C., Rosenbach, M., and can Rhee, F., et al. (2013). Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clue. JAMA Dermatol, 149, 204–8Google Scholar

Graham, J.S., and Schoneboom, B.A. (2013). Historical perspective on effects and treatment of sulfur mustard injuries. Chem Biol Interact, 206, 512–22CrossRefGoogle ScholarPubMed

Goh, S.G., and Calonje, E. (2008). Cutaneous vascular tumors: an update. Histopathology, 52, 661–73Google Scholar

Gupta, A., and Kozakewich, H. (2011). Histopathology of vascular anomalies. Clin Plast Surg, 38, 31–44CrossRefGoogle ScholarPubMed

Aboutalebi, A., Jessup, C.J., North, P.E., et al. (2012). Histopathology of vascular anomalies. Facial Plast Surg, 28, 545–53Google Scholar

Lee, P.W., Frieden, I.J., Streicher, J.L., et al. (2014). Characteristics of non-involuting congenital hemangioma: a retrospective review. J Am Acad Dermatol, 70, 899–903Google Scholar

North, P.E., Waner, M., James, C.A., et al. (2001). Congenital non-progressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol, 137, 1607–20Google Scholar

Nasseri, E., Piram, M., McCuaid, C.C., et al. (2014). Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol, 70, 75–9Google Scholar

Picardo, A., Boscolo, E., Khan, Z.A., et al. (2008). IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res, 63, 263–7Google Scholar

Brenn, T., and Fletcher, C.D. (2004). Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors. Am J Dermatopathol, 26, 14–21CrossRefGoogle ScholarPubMed

Zamecnik, M. (2004). Relationship between cutaneous epithelioid angiomatous nodule and epithelioid hemangioma. Am J Dermatopathol, 26, 351-2Google Scholar

Sangueza, O., Walsh, S.N., Sheehan, D.J., et al. (2008). Cutaneous epithelioid angiomatous nodule: a case series and proposed classification. Am J Dermatopathol, 30, 16–20Google Scholar

Leroy, X., Mortuaire, G., Chevalier, D., et al. (2008). Epithelioid angiomatous nodule of the nasal cavity. Pathol Res Pract, 204, 929–32Google Scholar

Pavlidakey, P.G., Burroughs, C., Karrs, T., et al. (2011). Cutaneous epithelioid angiomatous nodule: a case with metachronous lesions. Am J Dermatopathol, 33, 831–4Google Scholar

Shiomi, T., Kaddu, S., Yoshida, Y., et al. (2011). Cutaneous epithelioid angiomatous nodule arising in capillary malformation. J Cutan Pathol, 38, 372–5Google Scholar

Kantrow, S., Martin, J.D., Vnencak-Jones, C.L., et al. (2007). Cutaneous epithelioid angiomatous nodule: report of a case and absence of microsatellite instability. J Cutan Pathol, 34, 515–16Google Scholar

Fernandez-Flores, A. (2008). D2–40 and cutaneous epithelioid angiomatous nodule. Am J Dermatopathol, 30, 302-4Google Scholar

McLemore, M.S., Huo, L., Deavers, M.T., et al. (2011). Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol, 38, 818–22Google Scholar

Wells, G.C., and Whimster, I.W. (1969). Subcutaneous angiolymphoid hyperplasia with eosinophilia. Br J Dermatol, 81, 1–14Google Scholar

Wilson Jones, E., and Bleehen, S.S. (1969). Inflammatory angiomatous nodules with abnormal blood vessels occurring about the ears and scalp (pseudo or atypical pyogenic granuloma). Br J Dermatol, 81, 804–16Google Scholar

Olsen, T.G., and Helwig, E.B. (1985). Angiolymphoid hyperplasia with eosinophilia. J Am Acad Dermatol, 12, 781–96Google Scholar

Zamecnik, M. (2004). Relationship between cutaneous epithelioid angiomatous nodule and epithelioid hemangioma. Am J Dermatopathol, 26, 351–2Google Scholar

Anthony, F.C., Miller, J.A., Calonje, E., et al. (2005). Epithelioid haemangioma in association with a deep arteriovenous malformation. Clin Exp Dermatol, 30, 238–40Google Scholar

Hashimoto, T., Takenouchi, T., Ito, M. et al. (1998). Angiolymphoid hyperplasia with eosinophilia presenting multinucleated cells in histology: an ultrastructual study. J Cutan Pathol, 25, 322–6Google Scholar

Koubaa, W., Verdier, M., Perez, M., and Wechsler, J. (2008). Intra-arterial angiolymphoid hyperplasia with eosinophilia. J Cutan Pathol, 35, 495–8Google Scholar

Morton, K., Robertson, A.J., and Hadden, W. (1987). Angiolymphoid hyperplasia with eosinophilia: report of a case arising from the radial artery. Histopathology, 11, 963–9Google Scholar

Chan, J.K., Hui, P.K., Ng, C.S., et al. (1989). Epithelioid haemangioma (angiolymphoid hyperplasia with eosinophilia) and Kimura's disease in Chinese. Histopathology, 15, 557–74Google Scholar

Chan, J.K.C., Fletcher, C.D.M., and Hicklin, G.A. (1990). Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol, 14, 1036–46Google Scholar

Rongioletti, F., Gambina, C., and Lerza, R. (1994). Glomeruloid hemangioma: a cutaneous marker of POEMS syndrome. Am J Dermatopathol, 16, 175–8Google Scholar

Pina-Oviedo, S., Lopez-Patino, S., and Ortiz-Hidalgo, C. (2006). Glomeruloid hemangiomas localized to the skin of the trunk with no clinical features of POEMS syndrome. Int J Dermatol, 45, 1449–50Google Scholar

Velez, D., Delgado-Jimenez, Y., and Fraga, J. (2005). Solitary glomeruloid haemangioma without POEMS syndrome. J Cutan Pathol, 32, 449–52Google Scholar

Kishimoto, S., Takenaka, H., Shibagaki, R., et al. (2000). Glomeruloid hemangioma in POEMS syndrome shows two different immunophenotypic endothelial cells. J Cutan Pathol, 27, 87–92Google Scholar

Dispenzieri, A., Kyle, R.A., Lacy, M.Q., et al. (2003). POEMS syndrome: definitions and long-term outcome. Blood, 101, 2496–506Google Scholar

Ishikawa, O., Nihei, Y., and Ishikawa, H. (1987). The skin changes of POEMS syndrome. Br J Dermatol, 117, 523–6Google Scholar

Puig, L., Moreno, A., Domingo, P., et al. (1985). Cutaneous angiomas in POEMS syndrome. J Am Acad Dermatol, 112, 961–4Google Scholar

LeBoit, P.E., Salomon, A.R., Santa Cruz, D.J., and Wick, M.R. (1992). Angiomatosis with luminal cryoprotein deposition. J Am Acad Dermatol, 27, 969–73Google Scholar

Yamamoto, T., and Yokozeki, H. (2007). Increased expression of vascular endothelial growth factor and its receptor Flt-1 in glomeruloid haemangioma associated with Crow-Fukase syndrome. J Eur Acad Dermatol Venereol, 21, 417–19Google Scholar

Naversen, D.N., Trask, D.M., Watson, F.H., and Burket, J.M.(1993). Painful tumors of the skin: “LEND AN EGG”. J Am Acad Dermatol, 28, 298–300Google Scholar

Nuovo, M.A., Grimes, M.M., and Knowles, D.M.(1990). Glomus tumors: clinicopathologic and immunohistochemical analysis of forty cases. Surg Pathol, 3, 31Google Scholar

Mentzel, T., Hügel, H., and Kutzner, H.(2002). CD34-positive glomus tumor: clinicopathologic and immunohistochemical analysis of six cases with myxoid stromal changes. J Cutan Pathol, 29, 421–5Google Scholar

Vigovich, F.A., Hurt, M.A., and Santa Cruz, D.J. (2010). Sclerotic glomus tumor. Am J Dermatopathol, 32, 76–8Google Scholar

Folpe, A.L., Fanburg-Smith, J.C., Miettinen, M., and Weiss, S.W. (2001). Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol, 25, 1–12Google Scholar

Acebo, E., Val-Bernal, J.F., and Arce, F. (1997). Giant intravenous glomus tumor. J Cutan Pathol, 24, 384–9Google Scholar

Calonje, E., and Fletcher, C.D.(1995). Cutaneous intraneural glomus tumor. Am J Dermatopathol, 17, 395–8Google Scholar

Pulitzer, D.R., Martin, P.C., and Reed, R.J. (1995). Epithelioid glomus tumor. Hum Pathol, 26, 1022–7Google Scholar

Slater, D.N., Cotton, D.W., and Azzopardi, J.G. (1987). Oncocytic glomus tumor: a new variant. Histopathology, 11, 523–31Google Scholar

Albrecht, S., and Zbiernowski, I. (1990). Incidental glomus coccygeum. When a normal structure looks like a tumor. Am J Surg Pathol, 14, 922–4Google Scholar

Santa Cruz, D.J., and Aronberg, J. (1988). Targetoid hemosiderotic hemangioma. J Am Acad Dermatol, 19, 550–8Google Scholar

Guillou, L., Calonje, E., Speight, P., et al. (1999). Hobnail hemangioma. A pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma. Am J Surg Pathol, 23, 97–105Google Scholar

Mentzel, T., Partanen, T.A., and Kutzner, H. Hobnail hemangioma (“targetoid hemosiderotic hemangioma”): clinicopathologic and immunohistochemical analysis of 62 cases. (1999). J Cutan Pathol, 26, 279–86Google Scholar

Al Dhaybi, R., Lam, C., Hatami, A., et al. (2012). Targetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: a study of 12 pediatric cases. J Am Acad Dermatol, 66, 116–20Google Scholar

Chiller, K.G., Passarn, D., Frieden, L.L. (2002). Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol, 138, 1567–76Google Scholar

González-Crussi, F., and Reyes-Mugica, M. (1991). Cellular hemangiomas ‘hemangioendothelioma’ in infants. Light microscopic, immunohistochemical and ultrastructural observations. Am J Surg Pathol, 15, 769–78Google Scholar

Smoller, B.R., and Apfelberg, D.M. (1993). Infantile (juvenile) capillary hemangioma: a tumor of heterogenous cellular elements. J Cutan Pathol, 20, 330–6Google Scholar

Calonje, E., Mentzel, T., and Fletcher, C.D.M. (1995). Pseudomalignant perineural invasion in cellular (‘infantile’) capillary hemangiomas. Histopathology, 26, 159–64Google Scholar

North, P.E., Waner, M., Mizeracki, A., and Mihm, M.C. (2000). GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol, 31, 11–22Google Scholar

Clearkin, K.P., and Enzinger, F.M. (1976). Intravascular papillary endothelial hyperplasia. Arch Pathol Lab Med, 100, 441–4Google Scholar

Hashimoto, H., Daimaru, Y., and Enjoji, M. Intravascular papillary endothelial hyperplasia. A clinicopathologic study of 91 cases. Am J Dermatopathol, 5, 539–46Google Scholar

Harria, M.N., Desai, R., Chuang, T.Y., et al. (2000). Lobular capillary hemangiomas: An epidemiologic report, with emphasis on cutaneous lesions. J Am Acad Dermatol, 42, 1012–16Google Scholar

Cooper, P.H., McAllister, H.A., and Helwig, E.B. (1979). Intravenous pyogenic granuloma. Am J Surg Pathol, 3, 221–8Google Scholar

Fortna, R.R., and Junkins-Hopkins, J.M. (2007). A case of lobular capillary hemangioma (pyogenic granuloma), localized to the subcutaneous tissue, and a review of the literature. Am J Dermatopathol, 29, 408–11Google Scholar

Peachey, R.D., Lim, C.C., and Whimster, I.W. (1970). Lymphangioma of skin. A review of 65 cases. Br J Dermatol, 83, 519–27Google Scholar

Garzon, M.C., Huang, J.T., Enjolras, O., and Frieden, I.J. (2007). Vascular malformations: Part 1. J Am Acad Dermatol, 56, 353–70Google Scholar

Patel, G.A., and Schwartz, R.A. (2009). Cutaneous lymphangioma circumscriptum: frog spawn on the skin. Int J Dermatol, 48, 1290–5Google Scholar

Bhawan, J., Silva, C., and Taungjaruwinai, W.M. (2013). Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas. J Cutan Pathol, 40, 801–6Google Scholar

ISSVA classification for vascular anomalies. issva.org/classification. Accessed 1 February 2015Google Scholar

Requena, L., and Sangueza, O.P. (1997). Cutaneous vascular anomalies. Part 1. Hamartomas, malformations, and dilatation of pre-existing vessels. J Am Acad Dermatol, 37, 523–49Google Scholar

Gupta, A., and Kozakewich, H. (2011). Histopathology of vascular anomalies. Clin Plast Surg, 38, 31–44Google Scholar

Boon, L.M., Mulliken, J.B., Enjolras, O., and Vikkula, M. (2004). Glomuvenous malformation (glomangioma) and venous malformation. Arch Dermatol, 140, 971–6Google Scholar

Boon, L.M., Mulliken, J.B., Enjolras, O., and Vikkula, M. (2004). Glomuvenous malformation (glomangioma) and venous malformation. Arch Dermatol, 140, 971–6Google Scholar

Brouillard, P., Boon, L.M., Revencu, N., et al; GVM Study Group. (2013). Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol, 4, 157–64Google Scholar

ISSVA classification for vascular anomalies. issva.org/classification. Accessed 1 February 2015Google Scholar

Requena, L., and Sangueza, O.P. (1997). Cutaneous vascular anomalies. Part 1. Hamartomas, malformations, and dilatation of pre-existing vessels. J Am Acad Dermatol, 37, 523–49Google Scholar

Gupta, A., and Kozakewich, H. (2011). Histopathology of vascular anomalies. Clin Plast Surg, 38, 31–44Google Scholar

Larralde, M., Abad, M.E., Luna, P.C., and Hoffner, M.V. (2014). Capillary-malformation-arteriovenous malformation: a clinical review of 45 patients. Int J Dermatol, 53, 458–61Google Scholar

Revencu, N., Boon, L.M., and Mendola, A. (2013). RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat, 34, 1632–41Google Scholar

Salama, S.S. (2014). Cutaneous collagenous vasculopathy: a new case series with clinicopathologic and ultrstructural correlation, literature review and insight into pathogenesis. Am J Dermatopathol [Epub ahead of print].Google Scholar

Wilson Jones, E., Winkelmann, R.K., Zachary, C.B.,et al. (1990). Benign lymphangioendothelioma. J Am Acad Dermatol, 23, 229Google Scholar

Guillou, L., and Fletcher, C.D. (2000). Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series. Am J Surg Pathol, 24, 1047–57Google Scholar

Recelles, J.M., Diaz, J.L., Angulo, J., et al. (2012). Giant benign lymphangioendothelioma. J Cutan Pathol, 39, 950–6Google Scholar

Wang, L., Chen, L., Yang, X., et al. (2013). Benign lymphangioendothelioma: a clinical, histopathologic and immunohistochemical analysis of four cases. J Cutan Pathol, 40, 945–9Google Scholar

Hunt, S.J., Santa Cruz, D.J., and Barr, R.J. (1991).Microvenular hemangioma. J Cutan Pathol, 18, 235–40Google Scholar

Bantel, E., Grosshans, E., and Ortonne, J.P. (1989). Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives. Z Hautkr, 64, 1071–4.Google Scholar

Aloi, F., Tomasini, C., and Pippione, M. Microvenular hemangioma. (1993). Am J Dermatopathol, 15, 534–8Google Scholar

Ai, D.F., Li, Y., and Li, P. (2014). Multiple microvenular hemangiona: A case report. Oncol Lett, 7, 275–7Google Scholar

Xu, X.L., Xu, C.R., Chen, H., et al. (2010). Eruptive microvenular hemangiomas in 4 Chinese patients: clinicopathologic correlation and review of the literature. Am J Dermatopathol, 32, 837–40Google Scholar

Rikihisa, W., Yamamoto, O., Kohda, F., et al. (1999). Microvenular haemangioma in a patient with Wiskott‐Aldrich syndrome. Br J Dermatol, 141, 752–4Google Scholar

Chang, S.E., Roh, K.H., Lee, M.W., et al. (2003). Microvenular hemangioma in a boy with acute myelogenous leukemia. Pediatr Dermatol, 20, 266–7Google Scholar

Trindade, F., Kutzner, H., Requena, L., et al. (2012). Microvenular hemangioma-an immunohistochemical study of 9 cases. Am J Dermatopathol, 34, 810–12Google Scholar

Fernandez-Flores, A. (2008). Lack of expression of podoplanin by microvenular hemangioma. Pathol Res Pract, 204, 817–21Google Scholar

Granter, S.R., Badizadegan, K., and Fletcher, C.D. (1998). Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol, 22, 513–25Google Scholar

Mentzel, T., Dei Tos, A.P., Sapi, Z., and Kutzner, H. (2006). Myopericytoma of skin and soft tissues. Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol, 30, 104–13Google Scholar

Dray, M.S., McCarthy, S.W., Palmer, A.A., et al. (2006). Myopericytoma: a unifying term for a spectrum of tumors that show overlapping features with myofibroma. A review of 14 cases. J Clin Pathol, 59, 67–73Google Scholar

McMenamin, M.E., and Calonje, E. (2002). Intravascular myopericytoma. J Cutan Pathol, 29, 557–61Google Scholar

Díaz-Flores, L., Gutiérrez, R., Alvarez-Argüelles, H., et al. (2011). Myopericytoma and arterial intimal thickening: the relationship between myopericytes and myointimal cells. J Cutan Pathol, 38, 857–64Google Scholar

McMenamin, M.E., and Fletcher, C.D.M. (2002). Malignant myoperciytoma: expanding the spectrum of tumors with myopericytic differentiation. Histopathology, 41, 450–60Google Scholar

Lau, P.P., Wong, O.K., Lui, P.C., et al. (2009). Myopericytoma in patients with AIDS: a new class of Epstein-Barr virus-associated tumor. Am J Surg Pathol, 33, 1666–72Google Scholar

Matsuyama, A., Hisaoka, M., and Hashimoto, H. (2007). Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol, 38, 645–51Google Scholar

Suurmeijer, A.J., and Fletcher, C. (2007). Papillary hemangioma. Distinct cutaneous hemangiomas of the head and neck area containing eosinophilic hyaline globules. Histopathology, 51, 638–48Google Scholar

Suurmeijer, A.J.H. (2010). Papillary hemangiomas and glomeruloid hemangiomas are distinct clinicopathologic entities. Int J Surg Pathol, 18, 48–54Google Scholar

Martin, S., Pitcher, D., Tschen, J., et al. (1980). Reactive angioendotheliomatosis. J Am Acad Dermatol, 2, 117–23Google Scholar

McMenamin, M.E., and Fletcher, C.D. (2002). Reactive angioendotheliomatosis: a study of 15 cases demonstrating a wide clinicopathologic spectrum. Am J Surg Pathol, 26, 685–97Google Scholar

Krell, J.M., Sanchez, R.L., and Solomon, A.R. (1994). Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis. J Cutan Pathol, 21, 363–70Google Scholar

Calonje, E., and Fletcher, C.D.M. (1991). Sinusoidal hemangioma. Am J Surg Pathol, 15, 1130–5Google Scholar

Nakamura, M., and Miyachi, Y. (1999). Calcifying sinusoidal hemangioma on the back. Br J Dermatol, 141, 350–92Google Scholar

Ban, M., Kamiya, H., and Kitajima, Y. (2010). Giant sinusoidal hemangioma revealing diffuse ancient change: hyalinization and organized thrombi. Int J Dermatol, 49, 589–90Google Scholar

Weiss, S.W., and Enzinger, F.M. (1986). Spindle cell hemangioendothelioma. A low-grade angiosarcoma resembling a cavernous hemangioma and Kaposi's sarcoma. Am J Surg Pathol, 10, 521–30Google Scholar

Scott, G.A., and Rosai, J. (1988). Spindle cell hemangioendothelioma. Report of seven additional cases of a recently described vascular neoplasm. Am J Dermatopathol, 10, 281–8Google Scholar

Fletcher, C.D., Beham, A., and Schmid, C. (1991). Spindle cell haemangioendothelioma: a clinicopathologic and immunohistochemical study indicative of a non-neoplastic lesion. Histopathology, 18, 291–301Google Scholar

Perkins, P., and Weiss, S.W. (1996). Spindle cell hemangioendothelioma. An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol, 20, 1196–204Google Scholar

Requena, L., and Kutzner, H. (2013). Hemangioendothelioma. Semin Diagn Pathol, 30, 29–44.Google Scholar

Terada, T. (2010). Spindle cell hemangioma of the calf with myxoid stroma and pseudolipoblasts. J Dermatol, 37, 926–8.Google Scholar

Wang, L., Gao, T., and Wang, G. (2014). Expression of Prox1, D2–40, and WT1 in spindle cell hemangioma. J Cutan Pathol, 41, 447–50Google Scholar

Pansuriya, T.C., van Eijk, R., d'Adamo, P., et al. (2011). Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet, 43, e1256-e1261Google Scholar

Kurek, K.C., Pansuriya, T.C., van Ruler, M.A., et al. (2013). R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations. Am J Pathol, 182, 1494–500Google Scholar

Tsang, W.Y.W., Chan, J.K.C., Fletcher, C.D.M., et al. (1994). Symplastic hemangioma: a distinctive vascular neoplasm featuring bizarre stromal cells. Int J Surg Pathol, 1, 202Google Scholar

Kutzner, H., Winzer, M., and Mentzel, T. (2000). Symplastic hemangioma. Hautarzt, 51, 327–31Google Scholar

Goh, S.G., Dayrit, J.F., and Calonje, E. (2006). Symplastic hemangioma: report of two cases. J Cutan Pathol, 33, 735–40Google Scholar

Macmillan, A., and Champion, R.M. (1971). Progressive capillary haemangioma. Br J Dermatol, 85, 492.Google Scholar

Padilla, R.S., Orkin, M., and Rosai, J. (1987). Acquired “tufted” angioma (progressive capillary hemangioma). A distinctive clinicopathologic entity related to lobular capillary hemangioma. Am J Dermatopathol, 9, 292–300Google Scholar

Wilson Jones, E., and Orkin, M. (1989). Tufted angioma (angioblastoma). J Am Acad Dermatol, 20, 214–25Google Scholar

Osio, A., Fraitag, S., Hadj-Rabia, S., et al. (2010). Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature. Arch Dermatol, 146, 758–63Google Scholar

Lam, W.Y., Mac-Moune, , Lai, F., et al. (1994). Tufted angioma with complete regression. J Cutan Pathol, 21, 461–6Google Scholar

Kumakiri, M., Muramoto, F., Tsukinaga, I., et al. (1983). Crystalline lamellae in the endothelial cells of a type of hemangioma characterized by the proliferation of immature endothelial cells and pericytes-angioblastoma (Nakagawa). J Am Acad Dermatol, 8, 68–75Google Scholar

Fukunaga, M. (2000). Intravenous tufted angioma. APMIS, 108, 287–92Google Scholar

Bam, M., Kamiya, H., and Kitajima, Y. (2000). Tufted angioma of adult onset, revealing abundant eccrine glands and central regression. Dermatology, 201, 68–70Google Scholar

Sadeghpour, M., Antaya, R.J., Lazova, R., et al. (2012). Dilated lymphatic vessels in tufted angioma: a potential source of diagnostic confusion. Am J Dermatopathol, 34, 400–3Google Scholar

Le Huu, A.R., Jokinen, C.H., Rubin, B.P., et al. (2010). Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol, 34, 1563–73.Google Scholar

Imperial, R., Helwig, E.B. (1967). Verrucous hemangioma. A clinicopathologic study of 21 cases. Arch Dermatol, 96, 247–53Google Scholar

Trindade, F., Torreleo, A., Requena, L., et al. (2013). An immunohistochemical study of verrucous hemangiomas. J Cutan Pathol, 40, 472–6Google Scholar

Wang, L., Gao, T., and Wang, G. (2014). Verrucous hemangioma: a clinicopathologic and immunohistochemical analysis of 74 cases. J Cutan Pathol, 41, 823–30Google Scholar

Nayler, S.J., Rubin, B.P., Calonje, E., et al. (2000). Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. Am J Surg Pathol, 24, 352–61Google Scholar

Fukunaga, M., Suzuki, K., Saegusa, N., and Folpe, A.L. (2007). Composite hemangioendothelioma: report of 5 cases including one with associated Maffucci syndrome. Am J Surg Pathol, 31, 1567–72Google Scholar

Requena, L., Luis Diaz, J., Manzarbeitia, F., et al. (2008). Cutaneous composite hemangioendothelioma with satellitosis and lymph node metastases. J Cutan Pathol, 35, 225–30Google Scholar

Tsai, J.W., Huang, H.Y., Lee, J.C., et al. (2011). Composite haemangioendothelioma: report of four cases with emphasis on atypical clinical presentation. Pathology, 43, 176–80Google Scholar

McNab, P.M., Quigley, B.C., Glass, L.F., and Jukic, D.M. (2013). Composite hemangioendothelioma and its classification as a low-grade malignancy. Am J Dermatopathol, 35, 517–22Google Scholar

Billings, S.D., Folpe, A.L., and Weiss, S.W. (2003). Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol, 27, 48–57Google Scholar

Hornick, J.L., and Fletcher, C.D. (2011). Pseudomyogenic hemangioendothelioma: a distinctive often multicentric tumor with indolent behavior. Am J Surg Pathol, 35, 190–201Google Scholar

Requena, L., Santonja, C., Martinez-Amo, J.L., et al. (2013). Cutaneous epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma: a little-known low-grade cutaneous vascular neoplasm. JAMA Dermatol, 149, 459–65Google Scholar

Mirra, J.M., Kessler, S., Bhuta, S., and Eckardt, J. (1992). The fibroma-like variant of epithelioid sarcoma: a fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer, 69, 1382–95Google Scholar

Tan, S.H., and Ong, B.H. (2001). Spindle cell variant of epithelioid sarcoma: an easily misdiagnosed tumor. Australas J Dermatol, 42, 139–41Google Scholar

Requena, L., and Kutzner, H. (2013). Hemangioendothelioma. Semin Diagn Pathol, 30, 29–44Google Scholar

Radu, O., and Pantanowitz, L. (2013). Kaposi sarcoma. Arch Pathol Lab Med, 137, 289–94Google Scholar

Grayson, W., and Pantanowitz, L. (2008). Histologic variants of cutaneous Kaposi sarcoma. Diagn Pathol, 3, 31Google Scholar

O'Donnell, P.J., Pantanowitz, L., and Grayson, W. (2010). Unique histologic variants of cutaneous Kaposi sarcoma. Am J Dermatopathol, 32, 244–50Google Scholar

Konstantinopoulos, P.A., Dezube, B.J., and Pantanowitz, L. (2006). Morphologic and immunophenotypic evidence of in situ Kaposi's sarcoma. BMC Clin Pathol, 6, 7Google Scholar

Luzar, B., Antony, F., Ramdial, P.K., and Calonje, E. (2007). Intravascular Kaposi's sarcoma – a hitherto unrecognised phenomenon. J Cutan Pathol, 34, 861–4.Google Scholar

Cossu, S., Satta, R., Cottoni, F., et al. (1997). Lymphangioma-like variant of Kaposi's sarcoma: clinicopathologic study of seven cases with review of the literature. Am J Dermatopathol, 19, 16–22Google Scholar

Pantanowitz, L., and Duke, W.H. (2008). Lymphoedematous variants of Kaposi's sarcoma. J Eur Acad Dermatol Venereol, 22, 118–20Google Scholar

Pantanowitz, L., Dezube, B.J., Pinkus, G.S., and Tahan, S.R. (2004). Histologic characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol, 31, 26–34Google Scholar

Ramdial, P.K., Sing, Y., Naicker, S., et al. (2011). Langerhans cells in anaplastic Kaposi sarcoma with a paucivascular phenotype: a potential diagnostic pitfall. Pathol Int, 61, 221–7.Google Scholar

Ramdial, P.K., Sing, Y., Subrayan, S., et al. (2010). Granulomas in acquired immunodeficiency syndrome-associated cutaneous Kaposi sarcoma: evidence for a role for Mycobacterium tuberculosis. J Cutan Pathol, 37, 827–34.Google Scholar

Tsang, W.Y., and Chan, J.K. (1991). Kaposi-like hemangioendothelioma. A distinctive vascular neoplasm of the retroperitoneum. Am J Surg Pathol, 15, 982–9Google Scholar

Zukerberg, L.R., Nickoloff, B.J., and Weiss, S.W. (1993). Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol, 17, 321–8Google Scholar

Nakaya, T., Morita, K., Kurata, A., et al. (2014). Multifocal kaposiform hemangioendothelioma in multiple visceral organs: an autopsy of 9-day-old female baby. Hum Pathol, 45, 1773–7Google Scholar

Lyons, L.L., Mac-Moune Lai, P.E., North, F., et al. (2004). Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol, 28, 559–68Google Scholar

Croteau, S.E., Liang, M.G., Kozakewich, H.P., et al. (2013). Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr, 162, 142–7Google Scholar

Mendez, R., Capdevila, A., Tellado, M.G., et al. (2003). Kaposiform hemangioendothelioma associated with Milroy's disease (primary hereditary lymphedema). J Pediatr Surg, 38, E9–E12Google Scholar

Vin-Christian, K., McCalmont, T.H., and Frieden, I.J. (1997). Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol, 133, 1573–8Google Scholar

Brasanac, D., Janic, D., Boricic, I., et al. (2003). Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int, 53, 627–31Google Scholar

Le Huu, A.R., Jokinen, C.H., Rubin, B.P., et al. (2010). Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol, 34, 163–73. Erratum in Am J Surg Pathol 2011; 35(2): 314, Ruben, Brian P (corrected to Rubin, Brian P).Google Scholar

Arai, E., Kuramochi, A., Tsuchida, T., et al. (2006). Usefulness of D2–40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol, 33, 492–7Google Scholar

Weiss, S.W., and Enzinger, F.M. (1982). Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer, 50, 970–81Google Scholar

Dabska, M. (1969). Malignant endovascular papillary angioendothelioma of the skin in childhood. Clinicopathologic study of 6 cases. Cancer, 24, 503–10Google Scholar

Schwartz, R.A., Dabska, C., and Dabska, M. (2000). The Dabska tumor: a thirty year retrospect. Dermatology, 201, 1–5Google Scholar

Fanburg-Smith, J.C., Michal, M., Partanen, T.A., et al. (1999). Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels. Am J Surg Pathol, 23, 1004–10Google Scholar

Goh, S.G.N., and Calonje, E. (2008). Cutaneous vascular tumors: an update. Histopathology, 52, 661–73Google Scholar

Requena, L., and Kutzner, H. (2013). Hemangioendothelioma. Semin Diagn Pathol, 30, 29–44Google Scholar

Quecedo, E., Martinez-Escribano, J.A., Febrer, I., et al. (1996). Dabska tumor developing within a preexisting vascular malformation. Am J Dermatopathol, 18, 302–7Google Scholar

Emanuel, P.O., Lin, R., Silver, L., et al. (2008). Dabska tumor arising in lymphangioma circumscriptum. J Cutan Pathol, 35, 65–9Google Scholar

Folpe, A.L., Veikkola, T., Valtola, R., et al. (2000). Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol, 13, 180–5Google Scholar

Fukunaga, M. (2005). Expression of D2–40 in lymphatic endothelium of normal tissues and in vascular tumors. Histopathology, 46, 396–402Google Scholar

Calonje, E., Fletcher, C.D., Wilson-Jones, E., et al. (1994). Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol, 18, 115–25Google Scholar

Requena, L., and Kutzner, H. (2013). Hemangioendothelioma. Semin Diagn Pathol, 30, 29–44Google Scholar

Sanz-Trelles, A., Rodrigo-Fernandez, I., Ayala-Carbonero, A., and Contreras-Rubio, F. (1997). Retiform hemangioendothelioma. A new case in a child with diffuse endovascular papillary endothelial proliferation. J Cutan Pathol, 24, 440–4Google Scholar

Albertini, A.F., Brousse, N., Bodemer, C., et al. (2011). Retiform hemangioendothelioma developed on the site of an earlier cystic lymphangioma in a six-year-old girl. Am J Dermatopathol, 33, e84–7Google Scholar

Schommer, M., Herbst, R.A., Brodersen, J.P., et al. (2000). Retiform hemangioendothelioma: another tumor associated with human herpes virus type 8. J Am Acad Dermatol, 42, 290–2Google Scholar

Weiss, S.W., and Enzinger, F.M. (1982). Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer, 50, 970–81Google Scholar

Requena, L., and Kutzner, H. (2013). Hemangioendothelioma. Semin Diagn Pathol, 30, 29–44Google Scholar

Mentzel, T., Beham, A., Calonje, E., et al. (1997). Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol, 21, 366–74Google Scholar

Quante, M., Patel, N.K., Hill, S., et al. (1998). Epithelioid hemangioendothelioma presenting in the skin: a clinicopathologic study of eight cases. Am J Dermatopathol, 20, 541–6Google Scholar

Deyrup, A.T., Tighiouart, M., Montag, A.G., and Weiss, SW. (2008). Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol, 32, 924–7Google Scholar

Buehler, D., Rice, S.R., Moody, J.S., et al. (2014). Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol, 37, 473–9Google Scholar

Stewart, F.W., and Treves, N. (1948). Lymphangiosarcoma in post-mastectomy lymphedema. Cancer, 13, 97–106Google Scholar

Suchak, R., Thway, K., Zelger, B., et al. (2011). Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs. Am J Surg Pathol, 35, 60–9Google Scholar

Deyrup, A.T., Miettinen, M., North, P.E., et al. (2011). Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases. Am J Surg Pathol, 35, 70–5Google Scholar

Lazova, R., McNiff, J.M., Glusac, E.J., and Godic, A. (2009). Promontory sign – present in patch and plaque stage of angiosarcoma! Am J Dermatopathol, 31, 132–6Google Scholar

Wood, A., Mentzel, T., van Gorp, J., et al. (2014). The spectrum of rare morphologic variants of cutaneous epithelioid angiosarcoma. Histopathology [Epub ahead of print]Google Scholar

Liu, Y.C., and Fung, M.A. (2011). Angiosarcoma with pseudoepidermotropism in a patient with breast cancer: a mimic of epidermotropic metastatic adenocarcinoma. Am J Dermatopathol, 33, 400–2Google Scholar

Requena, L., Santonja, C., Stutz, N., et al. (2007). Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma. Am J Dermatopathol, 29, 342–50Google Scholar

Brightman, L.A., Demierre, M.F., and Byers, H.R. (2006). Macrophage-rich epithelioid angiosarcoma mimicking malignant melanoma. J Cutan Pathol, 33, 38–42Google Scholar

McKay, K.M., Doyle, L.A., Lazar, A.J., and Hornick, J.L. (2012). Expression of ERG, and Ets family transcription factor, distinguishes cutaneous angiosarcoma from histologic mimics. Histopathology, 61, 989–91Google Scholar

Antonescu, C.R., Yoshida, A., Guo, T., el al. (2009). KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res, 69, 7175–9Google Scholar

Manner, J., Radlwimmer, B., Hohenberger, P., et al. (2010). MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol, 176, 34–9.Google Scholar

Guo, T., Chang, N.E., Singer, S., et al. (2011). Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer, 50, 25–33.Google Scholar

Fernandez, A.P., Sun, Y., Tubbs, R.R., et al. (2012). FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol, 39, 234–42Google Scholar

Mentzel, T., Schildhaus, H.U., Palmedo, G., et al. (2012). Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol, 25, 75–85Google Scholar

Thum, C., Husain, E.A., Mulholland, K., et al. (2013). Atypical fibroxanthoma with pseudoangiomatous features: a histologic and immunohistochemical mimic of cutaneous angiosarcoma. Ann Diagn Pathol, 17, 502–7Google Scholar

Val-Bernal, J.F., Figols, J., Arce, F.P., and Sanz-Ortiz, J. (2001). Cardiac epithelioid angiosarcoma presenting as cutaneous metastases. J Cutan Pathol, 28, 265–70Google Scholar

Rudd, R.J., Fair, K.P., and Patterson, J.W. (2000). Aortic angiosarcoma presenting with cutaneous metastasis: case report and review of the literature. J Am Acad Dermatol, 43, 930–3Google Scholar

Fineberg, S., and Rosen, P.P. (1994). Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. Am J Clin Pathol, 102, 757–63Google Scholar

Brenn, T., and Fletcher, C.D.M. (2006). Postradiation vascular proliferations: an increasing problem. Histopathology, 48, 106–14Google Scholar

Fisher, C. (2013). Unusual myoid, perivascular, and postradiation lesions, with emphasis on atypical vascular lesion, postradiation cutaneous angiosarcoma, myoepithelial tumors, myopericytoma, and perivascular epithelioid cell tumor. Semin Diagn Pathol, 30, 73–84Google Scholar

Patton, K.T., Deyrup, A.T., and Weiss, S.W. (2008). Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analysing histologic heterogeneity and association with angiosacoma. Am J Surg Pathol, 32, 943–50Google Scholar

Ginter, P.S., Mosquera, J.M., MacDonald, T.Y., et al. (2014). Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites. Hum Pathol, 45, 709–16Google Scholar